HPV

Apr 22, 2020

Roche Diagnostics Q1 Sales Essentially Flat

Emergency testing related to the SARS-CoV-2 pandemic strongly increased, but routine testing declined due to fewer regular health checks.

Apr 21, 2020

Roche Gets FDA Approval for HPV Test Used With Cobas 6800/8800 Platforms

The test, which is used to screen for cervical cancer, was previously approved by the agency for use with the Cobas 4800 system.

Mar 26, 2020

Cervicovaginal Microbiomes of HPV-Infected Women Lead To Potential Pre-Cancer Marker

Profiling microbial communities in cervicovaginal samples from women carrying high-risk HPV strains, researchers found possible markers of pre-cancer progression.

Mar 24, 2020

HPV Head and Neck Cancer Recurrence Test Data Adds Validation as Naveris Ramps Clinical Launch

Premium

The company began offering testing to clinicians in the first quarter of this year and expects volume to grow significantly over the next several months.

Feb 10, 2020

PLOS Papers on MiRNA Target Evolution in Vertebrates, Circulating HPV in Cervical Cancer, More

In PLOS this week: signs of selection on microRNA targets, HPV sequences as markers of cervical cancer, and more.

Feb 06, 2020

BD Posts 2 Percent Gain in Fiscal Q1 Revenues but Lowers Guidance

The firm is lowering its guidance due to anticipated revenue loss related to remediation efforts associated with its Alaris pump system.

Jan 30, 2020

Atila Biosystems High-Throughput Isothermal HPV Test Validated in Study

Premium

The system showed good performance for cervical samples as well as orophyrengeal samples, and required no extraction step.

Jan 27, 2020

QuantuMDx Raises $14M to Support Development of POC Genotyping Assay

The company said it has started the CE mark approval process of commissioned high-risk HPV genotyping assays and expects to certify them this year.

Jan 23, 2020

Viral Cancer Early Detection Efforts Making Progress Toward the Clinic

Premium

Researchers are making improvements to viral-DNA detection methods and are exploring applications not just for screening but also disease monitoring.

Dec 03, 2019

Co-Diagnostics Joint Venture Gets Clearance in India for Five MDx Tests

The clearance covers tests made by the firm's joint venture for manufacturing, CoSara Diagnostics, in its facility in Ranoli, India.

Menu

HPV

Roche Diagnostics Q1 Sales Essentially Flat

Roche Gets FDA Approval for HPV Test Used With Cobas 6800/8800 Platforms

Cervicovaginal Microbiomes of HPV-Infected Women Lead To Potential Pre-Cancer Marker

HPV Head and Neck Cancer Recurrence Test Data Adds Validation as Naveris Ramps Clinical Launch

PLOS Papers on MiRNA Target Evolution in Vertebrates, Circulating HPV in Cervical Cancer, More

BD Posts 2 Percent Gain in Fiscal Q1 Revenues but Lowers Guidance

Atila Biosystems High-Throughput Isothermal HPV Test Validated in Study

QuantuMDx Raises $14M to Support Development of POC Genotyping Assay

Viral Cancer Early Detection Efforts Making Progress Toward the Clinic

Co-Diagnostics Joint Venture Gets Clearance in India for Five MDx Tests

Pages

Breaking News

Source Molecular, LuminUltra Partner for SARS-CoV-2 Environmental Testing

Fluidigm Leads May GenomeWeb Index on Early Detection SARS-Cov-2 Blood Test Collaboration Details

ACMG Offers Guidance on Incorporating Genomic Data into Electronic Health Records

CRISPR Researchers Develop Dual-Deaminase Base Editing Platforms

Ancient DNA Study in Northern China Links Population Migrations, Agriculture Shifts

Top Five Articles on GenomeWeb Last Week: Ginkgo Bioworks, LetsGetChecked, NantOmics, and More

The Scan

Trump Announces Departure From WHO

Also, Vacuums Are Just Scary

Limited Early Spread

PLOS Papers on Indonesian Archipelago Populations, Hookworm Secretome, Carotid Plaque GWAS